Literature DB >> 2983580

Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis.

R J Shaw, P Fitzharris, O Cromwell, A J Wardlaw, A B Kay.   

Abstract

Leukotrienes are a recently discovered group of arachidonic acid-derived lipid mediators. Using radioimmunoassay and high pressure liquid chromatography (HPLC), we have identified the SRS-A sulphidopeptide leukotrienes (LTC4, LTD4 and LTE4) in nasal washings from patients with allergic rhinitis who underwent nasal challenge with specific allergen. Smaller, but significant, amounts of LTB4 were also detected. The concentrations of nasal leukotrienes were directly related to the dose of allergen, and were recovered in washings in a time-dependent fashion after challenge. When the patients were subjected to methacholine nasal challenge on a control day, we found only negligible amounts of either the sulphidopeptide leukotrienes or LTB4. These findings support the view that LTC4, LTD4 and LTE4 might contribute to the pathogenesis of allergic rhinitis as a result of their recognized effects on mucous hypersecretion and vasopermeability, and that the potent chemoattractant LTB4 might be involved in the subsequent infiltration of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983580     DOI: 10.1111/j.1398-9995.1985.tb04147.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  10 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis.

Authors:  R A Simon
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

3.  Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.

Authors:  P N Black; R W Fuller; G W Taylor; P J Barnes; C T Dollery
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 4.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

5.  What's new about hay fever?

Authors:  S T Holgate; P H Howarth
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

6.  Immunology of allergic rhinitis, or a nose for treatment.

Authors:  V J Lund; D J Wright; R J Davies
Journal:  J R Soc Med       Date:  1986-10       Impact factor: 5.344

Review 7.  Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.

Authors:  I K Taylor
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

8.  Histamine and allergen induced changes in nasal airways resistance measured by anterior rhinomanometry: reproducibility of the technique and the effect of topically administered antihistaminic and anti-allergic drugs.

Authors:  O J Corrado; S Ollier; M J Phillips; J M Thomas; R J Davies
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

Review 9.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

10.  Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers.

Authors:  K A Callow; D A Tyrrell; R J Shaw; P Fitzharris; A J Wardlaw; A B Kay
Journal:  Clin Allergy       Date:  1988-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.